ivan_gold_star_

📉Record unemployment in the US -an opportunity to earn IPO ACCD

āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™
FRED:UNRATE   āļ­āļąāļ•āļĢāļēāļāļēāļĢāļ§āđˆāļēāļ‡āļ‡āļēāļ™āļ‚āļ­āļ‡āļ›āļĢāļ°āļŠāļēāļŠāļ™
🔎 Hello everyone! We have an interesting trading idea for you - how you can earn 50% or more on the exchange by participating in the initial placement of Accolade shares (ACCD). Accolade is a startup that has developed a healthcare platform for employers. The company's platform helps its users better navigate the healthcare system, as well as reduce costs for medical purposes. As you know, due to COVID-19, many companies now suffer huge costs and strive to optimize their performance as best as possible. By the way, unemployment in the US is now at a record level, which has not been recorded since the great depression (1929-1939) - see the chart.

ACC Accolade uses a range of technologies - from machine learning to mobile apps-to make it easier for employees to access medical care. Employers are charged a subscription fee depending on the number of employees. The volume of investments attracted by the company, according to crunchabase, amounts to $237.3 million. In addition, Accolade has bought the company and konciergeMD MD Insider. You can see the picture of the business structure of this company below.

ðŸĪ If you need statistics on the company's financial performance, you can write to me and I will send you a detailed report. If you do not know how to perform the operation and start from 25,000 rubles, you can also write to me, I will help you, but the deadline is 20-00 today in Moscow. Opportunities appear quickly and disappear just as quickly. I expect the return on this IPO to be around + 50% or higher, but I remind you that there is a risk of losing all or part of your capital, so invest no more than what you are prepared to lose.

📈 Graphs will be in the comments, so that the article is not blocked
āļ„āļģāļˆāļģāļāļąāļ”āļŠāļīāļ—āļ˜āļīāđŒāļ„āļ§āļēāļĄāļĢāļąāļšāļœāļīāļ”āļŠāļ­āļš

āļ‚āđ‰āļ­āļĄāļđāļĨāđāļĨāļ°āļšāļ—āļ„āļ§āļēāļĄāđ„āļĄāđˆāđ„āļ”āđ‰āļĄāļĩāļ§āļąāļ•āļ–āļļāļ›āļĢāļ°āļŠāļ‡āļ„āđŒāđ€āļžāļ·āđˆāļ­āļāđˆāļ­āđƒāļŦāđ‰āđ€āļāļīāļ”āļāļīāļˆāļāļĢāļĢāļĄāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™, āļāļēāļĢāļĨāļ‡āļ—āļļāļ™, āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒ, āļ‚āđ‰āļ­āđ€āļŠāļ™āļ­āđāļ™āļ° āļŦāļĢāļ·āļ­āļ„āļģāđāļ™āļ°āļ™āļģāļ›āļĢāļ°āđ€āļ āļ—āļ­āļ·āđˆāļ™ āđ† āļ—āļĩāđˆāđƒāļŦāđ‰āļŦāļĢāļ·āļ­āļĢāļąāļšāļĢāļ­āļ‡āđ‚āļ”āļĒ TradingView āļ­āđˆāļēāļ™āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ—āļĩāđˆ āđ€āļ‡āļ·āđˆāļ­āļ™āđ„āļ‚āļāļēāļĢāđƒāļŠāđ‰āļšāļĢāļīāļāļēāļĢ